| Primary information |
|---|
| ID | 11894 |
| Uniprot ID | Q867D0 |
| Description | Endothelin-2 (ET-2) (Preproendothelin-2) (PPET2) |
| Organism | Equus caballus |
| Txonomy | Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata (jawed vertebrates); Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Mammalia; Theria; Eutheria; Boreoeutheria; Laurasiatheria; Perissodactyla (odd-toed ungulates); Equidae (horses); Equus; Equus; Equus caballus (Horse) |
| Subcellular Location | Secreted |
| Developmental Stage | NA |
| Similarity | Belongs to the endothelin/sarafotoxin family. |
| Tissue Specificity | NA |
| Post Translational Modification | NA |
| Function | Endothelins are endothelium-derived vasoconstrictor peptides. |
| Length | 178 |
| Molecular Weight | 19 |
| Name | Endothelin-2 (ET-2) (Preproendothelin-2) (PPET2) |
| Sequence | CSCSSWLDKECVYFCHLDIIW |
| Sequence map | 21 |
| PDB ID | NA |
| Drugpedia | NA |
| Receptor | NA |
| Domain | NA |
| Pharmaceutical Use | NA
|